335 related articles for article (PubMed ID: 26039047)
1. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
Kanaoka R; Kushiyama A; Seno Y; Nakatsu Y; Matsunaga Y; Fukushima T; Tsuchiya Y; Sakoda H; Fujishiro M; Yamamotoya T; Kamata H; Matsubara A; Asano T
PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047
[TBL] [Abstract][Full Text] [Related]
2. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
Chen SY; Wulf G; Zhou XZ; Rubin MA; Lu KP; Balk SP
Mol Cell Biol; 2006 Feb; 26(3):929-39. PubMed ID: 16428447
[TBL] [Abstract][Full Text] [Related]
3. Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.
Endoh K; Nishi M; Ishiguro H; Uemura H; Miyagi Y; Aoki I; Hirano H; Kubota Y; Ryo A
Prostate; 2012 May; 72(6):626-37. PubMed ID: 21809350
[TBL] [Abstract][Full Text] [Related]
4. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
Ryo A; Uemura H; Ishiguro H; Saitoh T; Yamaguchi A; Perrem K; Kubota Y; Lu KP; Aoki I
Clin Cancer Res; 2005 Oct; 11(20):7523-31. PubMed ID: 16243827
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
[TBL] [Abstract][Full Text] [Related]
6. PIN1 inhibition suppresses osteoclast differentiation and inflammatory responses.
Cho YA; Jue SS; Bae WJ; Heo SH; Shin SI; Kwon IK; Lee SC; Kim EC
J Dent Res; 2015 Feb; 94(2):371-80. PubMed ID: 25512367
[TBL] [Abstract][Full Text] [Related]
7. The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas.
Wiegand S; Dakic B; Rath AF; Makarova G; Sterz C; Meissner W; Bette M; Adamkiewicz J; Müller-Brüsselbach S; Müller R; Werner JA; Mandic R
Oral Oncol; 2009 Oct; 45(10):e140-9. PubMed ID: 19502098
[TBL] [Abstract][Full Text] [Related]
8. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
Mathur R; Chandna S; N Kapoor P; S Dwarakanath B
Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380
[TBL] [Abstract][Full Text] [Related]
9. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression.
Yun HJ; Kim JY; Kim G; Choi HS
Anticancer Res; 2014 Mar; 34(3):1409-16. PubMed ID: 24596388
[TBL] [Abstract][Full Text] [Related]
10. Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family.
Fan G; Fan Y; Gupta N; Matsuura I; Liu F; Zhou XZ; Lu KP; Gélinas C
Cancer Res; 2009 Jun; 69(11):4589-97. PubMed ID: 19458071
[TBL] [Abstract][Full Text] [Related]
11. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription.
Chao SH; Greenleaf AL; Price DH
Nucleic Acids Res; 2001 Feb; 29(3):767-73. PubMed ID: 11160900
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.
Xu M; Cheung CC; Chow C; Lun SW; Cheung ST; Lo KW
PLoS One; 2016; 11(6):e0156833. PubMed ID: 27258148
[TBL] [Abstract][Full Text] [Related]
13. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
[TBL] [Abstract][Full Text] [Related]
14. Pin1 inhibitor Juglone prevents diabetic vascular dysfunction.
Costantino S; Paneni F; Lüscher TF; Cosentino F
Int J Cardiol; 2016 Jan; 203():702-7. PubMed ID: 26583846
[TBL] [Abstract][Full Text] [Related]
15. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
16. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
17. Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2009 Dec; 22(6):1451-8. PubMed ID: 19885599
[TBL] [Abstract][Full Text] [Related]
18. Effect of Pin1 inhibitor juglone on proliferation, migration and angiogenic ability of breast cancer cell line MCF7Adr.
Hu YG; Shen YF; Li Y
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):531-534. PubMed ID: 26223922
[TBL] [Abstract][Full Text] [Related]
19. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
[TBL] [Abstract][Full Text] [Related]
20. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.
Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L
Tumori; 2016; 102(2):144-9. PubMed ID: 26917410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]